[HTML][HTML] Emerging therapeutic opportunities for integrin inhibitors

RJ Slack, SJF Macdonald, JA Roper… - Nature Reviews Drug …, 2022 - nature.com
Integrins are cell adhesion and signalling proteins crucial to a wide range of biological
functions. Effective marketed treatments have successfully targeted integrins αIIbβ3 …

[PDF][PDF] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance

J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …

[HTML][HTML] Phase 0/microdosing approaches: time for mainstream application in drug development?

T Burt, G Young, W Lee, H Kusuhara… - Nature Reviews Drug …, 2020 - nature.com
Phase 0 approaches—which include microdosing—evaluate subtherapeutic exposures of
new drugs in first-in-human studies known as exploratory clinical trials. Recent progress …

[HTML][HTML] ImmunoPET: antibody-based PET imaging in solid tumors

R Manafi-Farid, B Ataeinia, S Ranjbar… - Frontiers in …, 2022 - frontiersin.org
Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

[HTML][HTML] A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose …

TM Maher, JK Simpson, JC Porter, FJ Wilson… - Respiratory …, 2020 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …

Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma

SH Hausner, RJ Bold, LY Cheuy, HK Chew… - Clinical Cancer …, 2019 - AACR
Purpose: The study was undertaken to develop and evaluate the potential of an integrin
αvβ6-binding peptide (αvβ6-BP) for noninvasive imaging of a diverse range of malignancies …

Homing peptides for cancer therapy

P Lingasamy, T Teesalu - Bio-nanomedicine for cancer therapy, 2021 - Springer
Tumor-homing peptides are widely used for improving tumor selectivity of anticancer drugs
and imaging agents. The goal is to increase tumor uptake and reduce accumulation at …

[HTML][HTML] Novel tracers for molecular imaging of interstitial lung disease: A state of the art review

B Broens, JW Duitman, GJC Zwezerijnen… - Autoimmunity …, 2022 - Elsevier
Interstitial lung disease is an overarching term for a wide range of disorders characterized by
inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include …

[HTML][HTML] Delivery of theranostic nanoparticles to various cancers by means of integrin-binding peptides

EA Egorova, MP Nikitin - International Journal of Molecular Sciences, 2022 - mdpi.com
Active targeting of tumors is believed to be the key to efficient cancer therapy and accurate,
early-stage diagnostics. Active targeting implies minimized off-targeting and associated …

Clinical translation of a 68Ga-labeled integrin αvβ6–targeting cyclic radiotracer for PET imaging of pancreatic cancer

X Feng, Y Wang, D Lu, X Xu, X Zhou… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The overexpression of integrin αvβ6 in pancreatic cancer makes it a promising target for
noninvasive PET imaging. However, currently, most integrin αvβ6–targeting radiotracers are …